Ironwood Pharmaceuticals logo
Ironwood Pharmaceuticals IRWD
$ 3.37 -4.4%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Ironwood Pharmaceuticals Balance Sheet 2011-2024 | IRWD

Annual Balance Sheet Ironwood Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

109 M -257 M -280 M 70.8 M 254 M 241 M 366 M 564 M 117 M 99.3 M 221 M -136 M -86.6 M

Long Term Debt

198 M 396 M 337 M 430 M 408 M 366 M 396 M 366 M 354 M 162 M 175 M - -

Long Term Debt Current

3.13 M 3.06 M 3.13 M 3.13 M 1.15 M - - - - - - - -

Total Non Current Liabilities

- - - - 455 M 409 M 530 M 552 M 448 M 184 M 200 M 30.9 M 34 M

Total Current Liabilities

276 M 25.5 M 162 M 32.2 M 40.9 M 120 M 66 M 91.1 M 76.5 M 60.5 M 41 M 54.9 M 65.1 M

Total Liabilities

- - - - 496 M 528 M 596 M 643 M 524 M 245 M 241 M 85.9 M 99.1 M

Deferred Revenue

2.6 M - - - 875 K - - - 7.19 M 7.19 M 5.07 M 3.38 M 36.3 M

Retained Earnings

-1.7 B -696 M -938 M -1.47 B -1.57 B -1.59 B -1.31 B -1.19 B -1.11 B -967 M -778 M -505 M -432 M

Total Assets

471 M 1.1 B 1.13 B 559 M 403 M 332 M 606 M 710 M 619 M 334 M 279 M 230 M 209 M

Cash and Cash Equivalents

92.2 M 656 M 620 M 363 M 177 M 173 M 126 M 54 M 261 M 74.3 M 75.5 M 137 M 87.3 M

Book Value

471 M 1.1 B 1.13 B 559 M -93.3 M -196 M 9.85 M 66.7 M 95.1 M 88.6 M 38.2 M 144 M 110 M

Total Shareholders Equity

-346 M 652 M 606 M 62.6 M -93.3 M -196 M 9.85 M 66.7 M 95.1 M 88.6 M 38.2 M 144 M 110 M

All numbers in USD currency

Quarterly Balance Sheet Ironwood Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

199 M 199 M 398 M 398 M 397 M 397 M 397 M 396 M 396 M - 516 M 454 M 448 M 442 M 436 M 430 M 425 M 430 M 430 M 408 M 403 M 408 M 408 M 266 M 266 M 266 M 266 M 249 M 249 M 249 M 249 M - - - - 221 M - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

1.9 M 2.1 M 1.7 M 2.6 M 2.6 M 1.5 M - - - - - - - - - - 875 K 875 K 875 K 875 K 875 K 875 K 875 K - 13.5 M - - - - 225 K 741 K - 4.13 M 8.52 M 9.31 M 7.19 M 7.19 M 7.19 M 7.19 M 7.19 M 7.19 M 7.19 M 7.19 M 5.07 M 5.07 M 5.07 M 5.07 M 3.38 M 3.38 M 3.38 M 3.38 M 36.3 M 36.3 M 36.3 M 36.3 M

Retained Earnings

-1.7 B -1.7 B -1.7 B -1.7 B -1.7 B -1.71 B -651 M -696 M -745 M - -833 M -938 M -979 M -1.03 B -1.43 B -1.47 B -1.47 B -1.47 B -1.47 B -1.57 B -1.57 B -1.57 B -1.57 B -1.59 B -1.59 B -1.59 B -1.59 B -1.31 B -1.31 B -1.31 B -1.31 B -1.19 B -1.19 B -1.19 B -1.19 B -1.11 B -1.11 B -1.11 B -1.11 B -967 M -967 M -967 M -967 M -778 M -778 M -778 M -778 M -505 M -505 M -505 M -505 M -432 M -432 M -432 M -432 M

Total Assets

390 M 396 M 439 M 471 M 524 M 603 M 1.16 B 1.1 B 1.04 B - 1.08 B 1.13 B 1.08 B 1.01 B 599 M 559 M 559 M 559 M 559 M 403 M 403 M 403 M 403 M 332 M 332 M 332 M 332 M 606 M 606 M 606 M 606 M 710 M 710 M 710 M 710 M 619 M 619 M 619 M 619 M 329 M 329 M 329 M 334 M 279 M 279 M 279 M 279 M 230 M 230 M 230 M 230 M 209 M 209 M 209 M 209 M

Cash and Cash Equivalents

88.2 M 106 M 122 M 92.2 M 110 M 175 M 740 M 656 M 574 M 504 M 593 M 620 M 574 M 493 M 438 M 363 M 363 M 363 M 363 M 177 M 177 M 177 M 177 M 173 M 173 M 173 M 173 M 126 M 126 M 126 M 126 M 54 M 54 M 54 M 54 M 261 M 261 M 261 M 261 M 74.3 M 74.3 M 74.3 M 74.3 M 75.5 M 75.5 M 75.5 M 75.5 M 137 M 137 M 137 M 137 M 87.3 M 87.3 M 87.3 M 87.3 M

Book Value

390 M 396 M 439 M 471 M 524 M 603 M 1.16 B 1.1 B 1.04 B - 1.08 B 1.13 B 1.08 B 1.01 B 599 M 559 M 559 M 559 M 559 M 403 M 403 M 403 M 403 M 332 M 332 M 332 M 332 M 606 M 606 M 606 M 606 M 710 M 710 M 710 M 710 M 619 M 619 M 619 M 619 M 329 M 329 M 329 M 334 M 279 M 279 M 279 M 279 M 230 M 230 M 230 M 230 M 209 M 209 M 209 M 209 M

Total Shareholders Equity

-311 M -322 M -331 M -346 M -326 M -347 M 707 M 652 M 591 M 533 M 518 M 606 M 580 M 512 M 110 M 62.6 M 62.6 M 62.6 M 62.6 M -93.3 M -93.3 M -93.3 M -93.3 M -196 M -196 M -196 M -196 M 9.85 M 9.85 M 9.85 M 9.85 M 66.7 M 66.7 M 66.7 M 66.7 M 95.1 M 95.1 M 95.1 M 95.1 M 88.6 M 88.6 M 88.6 M 88.6 M 38.2 M 38.2 M 38.2 M 38.2 M 144 M 144 M 144 M 144 M 110 M 110 M 110 M 110 M

All numbers in USD currency